NFKB1 and nonpapillary renal cell carcinoma: These results suggest that XMU-MP-1 inhibits NF-κB target gene expression in a dose- and time-dependent manner and that this downregulation is not due to a change in the abundance of p65, a major subunit of NF-κB in ccRCC (32).